Sign inJoin waitlistJoin the waitlist

John Richart

Physician · SLUcare Physician Group

Credentials: · · · ·

History

SLUcare Physician Group
2022–Present

Hematology and Medical Oncology
SSM Health Saint Louis University Hospital
1996–1999
Internal Medicine
Washington University School of Medicine
1993–1996
University of Missouri School of Medicine
1989–1993

Research

Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition
Journal for ImmunoTherapy of Cancer · 2019 · 128 citations
Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT
Review · Bone Marrow Transplantation · 2017 · 55 citations
Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT
Biology of Blood and Marrow Transplantation · 2016 · 48 citations

MF
Mark Fesler
5 papers
PP
Paul Petruska
4 papers
Brendan Curti
3 papers
David McDermott
3 papers
Gregory Daniels
3 papers
Joseph Clark
3 papers
MC
Melinda Chu
3 papers
RG
Rene Gonzalez-Cotarelo
3 papers
Sapna Patel
3 papers
Adrian Di Bisceglie
2 papers
Adriana Malone
2 papers
AS
Amir Steinberg
2 papers

Clinical trials

Neoadjuvant Pembrolizumab for Unresectable Stage III and Unresectable Stage IV Melanoma
Principal investigator · Completed · Phase 2
St. Louis University
2015–2018
Fosaprepitant for N/V With High-dose Interleukin-2 for Metastatic Melanoma and Renal Cell Carcinoma
Principal investigator · Terminated · Phase 2
St. Louis University
2013–2015